Platelet activation in congenital heart diseases

Pediatrics International

Volumn 39, Issue 5, 1997, Pages 566-569

  Olgun, Nur ^a   Uysal, Kamer MutafoǦlu ^a   Irken, Gülersu ^a   ünal, Nurettin ^a   ündar, Bülent ^a   AkkoÇ, Nurullah ^a   AkÇoral, Adnan ^a   SarialioǦlu, Faik ^a   Çevik, Namik ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Arterial oxygen saturation; Cyanotic congenital heart disease; Platelet activation

Indexed keywords

MONOCLONAL ANTIBODY;

ARTICLE; BLEEDING DISORDER; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CYANOSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ERYTHROCYTE LEVEL; FEMALE; FLOW CYTOMETRY; HUMAN; HYPOTHESIS; MALE; POLYCYTHEMIA; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE ACTIVATION; THROMBOSIS;

CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; MALE; OXYGEN; PLATELET ACTIVATION; PLATELET COUNT;

EID: 0030870135     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.1997.tb03642.x     Document Type: Article

References (14)

1. Phornphutkul C., Rosenthal S., Nadas AS, Berenberg W. Cerebrovascular accidents in infants and children with cyanotic congenital heart disease. Am. J. Cardiol. 1973; 22: 219–24.
2. Ekert H., Sheers M. Preoperative and postoperative platelet function in cyanotic congenital heart disease. J. Thorac. Cardiovasc. Surg. 1974; 67: 184–990.
3. Maurer HM, McCue CM, Caul J., Still WJS. Impairment in platelet aggregation in congenital heart disease. Blood 1972; 40: 207–16.
4. Henriksson P., Varendh G., Lundström NR. Haemostatic defects in cyanotic congenital heart disease. Br. Heart J. 1979; 41: 23–7.
5. Waldman JD, Czapek EE, Paul MH, Schwartz AD, Levin DL, Schindler S. Shortened platelet survival in cyanotic heart disease. J. Pediatr. 1975; 87: 77–9.
6. Wu G., Li, J. et al. Detection of activated platelet using activation-dependent monoclonal antibody SZ-51 in clinical disorders. Nouv. Rev. Fr. Hematol. 1992; 34: 31–5.
7. Gottl, Nowak U., Kreuz WD, Krackhardt B. et al. Gerinnungsphysiologische untersuchungen bei idiopathischen arteriellen Thrombosen. Monatsschr. Kinderheilled. 1992; 140: 183–7.
8. Stenberg PE, McEver RP, Schuman MA et al. A platelet alpha granule membrane protein GMP-140 is expressed on the plasma membrane after activation. J. Cell Biol. 1985; 101: 880–6.
9. Rinder CS, Bohnet J., Rinder HM et al. Platelet activation and aggregation during cardiopulmonary bypass. Anesthesiology 1991; 75: 388–93.
10. Abrams C., Shattil SJ. Immunologic detection of activated platelets in clinical disorders Thromb. Haemost. 1991; 65: 467–73.
11. Gasperetti CM, Gronias SL, Gimple LW, Powers ER. Platelet activation during angioplasty in humans. Circulation 1993; 88: 2728–34.
12. Rinder CS, Gaal D., Student LA, Smith BR. Platelet-leucocyte activation and modulation of adhesion receptors in pediatric patients with congenital heart disease undergoing cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 1994; 107: 280–8.
13. Rinder CS, Bonan JL, Rinder HM, Mathews J., Hines R., Smith BR. Cardiopulmonary bypass induced leucocyte-platelet adhesion. Blood 1992; 79: 1202–5.
14. Brandt CM, Lanza F., Gachet C., Hemmendinger S., Cazenave JP. Platelet activation revealed by reduced serotonin content in various left ventricular hypertrophic states. Acta Cardiolog. 1992; 3: 271–4.